327 related articles for article (PubMed ID: 28691019)
1. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.
Wang H; Shao Y; Yuan F; Feng H; Li N; Zhang H; Wu C; Liu Z
Biomed Res Int; 2017; 2017():2503847. PubMed ID: 28691019
[TBL] [Abstract][Full Text] [Related]
2. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
3. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
4. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
5. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
[TBL] [Abstract][Full Text] [Related]
6. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
[TBL] [Abstract][Full Text] [Related]
7. Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats.
Roberts MD; Mobley CB; Toedebush RG; Heese AJ; Zhu C; Krieger AE; Cruthirds CL; Lockwood CM; Hofheins JC; Wiedmeyer CE; Leidy HJ; Booth FW; Rector RS
BMC Gastroenterol; 2015 Oct; 15():151. PubMed ID: 26519296
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.
Zhu M; Wang Q; Zhou W; Liu T; Yang L; Zheng P; Zhang L; Ji G
Sci Rep; 2018 May; 8(1):7628. PubMed ID: 29769539
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-34a-5p antagonizes AFB1-induced genotoxicity in F344 rat liver.
Liu C; Yu H; Zhang Y; Li D; Xing X; Chen L; Zeng X; Xu D; Fan Q; Xiao Y; Chen W; Wang Q
Toxicon; 2015 Nov; 106():46-56. PubMed ID: 26385312
[TBL] [Abstract][Full Text] [Related]
11. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG
World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651
[TBL] [Abstract][Full Text] [Related]
12. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.
Tian Y; Wang H; Yuan F; Li N; Huang Q; He L; Wang L; Liu Z
Biomed Res Int; 2016; 2016():9462571. PubMed ID: 27051672
[TBL] [Abstract][Full Text] [Related]
13. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
14. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
Braza-Boïls A; Marí-Alexandre J; Molina P; Arnau MA; Barceló-Molina M; Domingo D; Girbes J; Giner J; Martínez-Dolz L; Zorio E
Liver Int; 2016 Aug; 36(8):1221-9. PubMed ID: 26901384
[TBL] [Abstract][Full Text] [Related]
15. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing.
Zhang Y; Xiang D; Hu X; Ruan Q; Wang L; Bao Z
Ann Hepatol; 2020; 19(3):302-312. PubMed ID: 31899128
[TBL] [Abstract][Full Text] [Related]
16. Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues.
Nie J; Li CP; Li JH; Chen X; Zhong X
Mol Med Rep; 2018 Sep; 18(3):2669-2680. PubMed ID: 30015905
[TBL] [Abstract][Full Text] [Related]
17. A micro-RNA expression signature for human NAFLD progression.
Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
[TBL] [Abstract][Full Text] [Related]
18. RATEmiRs: the rat atlas of tissue-specific and enriched miRNAs database.
Bushel PR; Caiment F; Wu H; O'Lone R; Day F; Calley J; Smith A; Li J
BMC Genomics; 2018 Nov; 19(1):825. PubMed ID: 30453895
[TBL] [Abstract][Full Text] [Related]
19. Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease.
Zhang D; Wang Y; Ji Z; Wang Z
Gene; 2016 Jul; 585(1):1-8. PubMed ID: 26971813
[TBL] [Abstract][Full Text] [Related]
20. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
